4147.TWO · TMB
Taiwan · RS rating 30 · As of 2026-10-08
| Price | 61.20 TWD |
|---|---|
| 1-day change | -1.1% |
| RS rating (overall / 1M / 3M / 12M) | 30 / 29 / 23 / 25 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 29 / 24 / 14 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | -550.0% |
| Sales growth Q/Q | -6.2% |
| Distance from 52-week high | +20.9% |
| Market cap (USD) | $520.5M |